HBM Holdings Limited
HBM Holdings Limited (HBMHF) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
hbmhf · pe ratio · data through Jun 9, 2026
Core PE Ratio Metrics
Trailing 12 months · TTMInsufficient PE history data (fewer than 3 valid fiscal years).
PE Ratio vs Peers
Biotechnology · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
HBM Holdings LimitedYou HBMHF | $2.1B | N/A | — | — |
 Acumen Pharmaceuticals, Inc. ABOS | $137M | N/A | — | -$2.00 |
 Acurx Pharmaceuticals, Inc. ACXP | $3M | N/A | — | -$5.31 |
 Anebulo Pharmaceuticals, Inc. ANEB | $15M | N/A | — | -$0.25 |
 Bio-Path Holdings, Inc. BPTH | $0M | N/A | — | -$1.10 |
 Cingulate Inc. CING | $27M | N/A | — | -$4.13 |
 Day One Biopharmaceuticals, Inc. DAWN | $2.2B | N/A | — | -$1.04 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for HBM Holdings Limited (HBMHF) measures how much investors pay for each dollar of the company's trailing earnings. HBMHF's current PE ratio of N/A is calculated by dividing its stock price of $2.52 by its TTM earnings per share of —.
Frequently asked questions
HBMHF pe ratio · 6 questionsHBMHF's current PE ratio is N/A as of 2026-06-09, based on a stock price of $2.52 and TTM EPS of —. Data sourced from Financial Modeling Prep via HBMHF's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · HBM Holdings Limited SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09